Search results

1. Biokoniugaty radioaktywnych nanocząstek platyny do celowanej terapii elektronami Auger

Principal investigator: prof. Aleksander Józef Bilewicz

Instytut Chemii i Techniki Jądrowej

Call: OPUS 18, Panel: ST4

2. Cuproptosis, a novel pathway of regulated cell death as a therapeutic target in treatment-naïve and targeted therapy-res…

Principal investigator: dr hab. Mariusz Łukasz Hartman

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Call: OPUS 25, Panel: NZ5

3. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

Principal investigator: dr Daria Nawrocka

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SONATINA 9, Panel: NZ6

4. The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

Principal investigator: dr Michał Jerzy Woźniak

Uniwersytet Medyczny w Łodzi

Call: OPUS 28, Panel: NZ7

5. Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to …

Principal investigator: Marika Anna Frańczak

Gdański Uniwersytet Medyczny, Wydział Lekarski

Call: PRELUDIUM 22, Panel: NZ7

6. Research on the preparation of new, hydrogel nanosystems for targeted therapy of colorectal cancer

Principal investigator: dr Urszula Helena Piotrowska

Warszawski Uniwersytet Medyczny

Call: SONATA 18, Panel: NZ7

7. Investigating the role of fibroblast growth factor receptors and STAT transcription factors in the targeted therapy of a…

Principal investigator: prof. Ewa Teresa Marcinkowska

Uniwersytet Wrocławski, Wydział Biotechnologii

Call: PRELUDIUM BIS 4, Panel: NZ5

8. Bioconjugates of 103Pd nanostructures for targeted Auger electron therapy.

Principal investigator: dr hab. Agnieszka Majkowska-Pilip

Instytut Chemii i Techniki Jądrowej

Call: OPUS 23, Panel: ST5

9. Synthetic epidermal growth factor receptor inhibitor conjugated with nobel metal nanoparticles as a potential drug for t…

Principal investigator: Shaoshan Mai

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

Call: PRELUDIUM 20, Panel: NZ7

10. Bioconjugates of gold nanoparticles coated by 197/197mHg for Auger electron targeted therapy

Principal investigator: Emilia Teresa Majka

Instytut Chemii i Techniki Jądrowej

Call: PRELUDIUM 20, Panel: ST5

11. New insights into multifaceted targeted therapy for treatment of glioblastoma multiforme.

Principal investigator: dr Katarzyna Anna Malarz

UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych

Call: OPUS 18, Panel: NZ5

12. Bioconjugates labeled with alpha- and beta-particle emitting radionuclides as potential radiopharmaceuticals in Targeted…

Principal investigator: dr hab. Marek Pruszyński

Instytut Chemii i Techniki Jądrowej

Call: SONATA BIS 9, Panel: ST4

13. Definition of targetable signaling pathways in chronic lymphocytic leukemia patients with rationale to novel therapy wit…

Principal investigator: Joanna Knap

Uniwersytet Medyczny w Lublinie, II Wydział Lekarski z Oddziałem Anglojęzycznym

Call: PRELUDIUM 16, Panel: NZ5

14. The use of insulin and glucose conjugates for the targeted therapy of breast cancer

Principal investigator: Siddarth Agrawal

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski

Call: PRELUDIUM 10, Panel: NZ5

15. Physicochemical characterization of cyclodextrins tailored for pH-dependent targeted therapy with anthracycline drugs

Principal investigator: prof. Renata Bilewicz

Uniwersytet Warszawski, Wydział Chemii

Call: OPUS 7, Panel: ST5

16. Synthesis of new phthalocyanines for targeted photodynamic cancer therapy.

Principal investigator: dr Łukasz Andrzej Łapok

Uniwersytet Jagielloński, Wydział Chemii; Zespół Nanotechnologii Polimerów i Biomateriałów

Call: SONATA 2, Panel: ST5

17. New drug carriers in targeted anticancer therapy

Principal investigator: prof. Artur Piotr Terzyk

Uniwersytet Mikołaja Kopernika, Wydział Chemii

Call: OPUS 1, Panel: ST5

18. Nanozeolites as a carriers of radium radionuclides in targeted therapy.

Principal investigator: prof. Aleksander Józef Bilewicz

Instytut Chemii i Techniki Jądrowej

Call: HARMONIA 1, Panel: ST4

19. Where Inhibition is not Enough- Development of Innovative Compounds for Targeted Degradation of Extracellular and Membra…

Principal investigator: dr Marcin Skoreński

Politechnika Wrocławska

Call: OPUS 28 (LAP), Panel: NZ5

20. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

Principal investigator: dr Marco Deiana

Politechnika Wrocławska

Call: SONATA BIS 14, Panel: NZ5

21. Perinuclear AKAP6 signalosome as a new target for gene therapy in ischemic optic neuropathy

Principal investigator: dr hab. Tomasz Boczek

Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

Call: OPUS 22, Panel: NZ4

22. Light-producing, oxygen-delivering, cancer cell-targeted carriers for photosensitisers dedicated for photodynamic therap…

Principal investigator: prof. Marek Arkadiusz Murias

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: OPUS 22, Panel: NZ7

23. Identification and use of natural human-tropic AAVs as vectors for gene therapy applications targeting human liver.

Principal investigator: prof. Leszek Lisowski

Wojskowy Instytut Medyczny

Call: OPUS 21, Panel: NZ5

24. In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno…

Principal investigator: Anna Karolina Pogorzelska

Narodowy Instytut Leków

Call: PRELUDIUM 20, Panel: NZ7

25. Novel approach in the search for asthma and COPD therapies - computer aided design of multi-target-directed ligands bloc…

Principal investigator: Alicja Aleksandra Gawalska

Uniwersytet Jagielloński, Collegium Medicum

Call: PRELUDIUM 19, Panel: NZ7

26. Bioconjugates of multimodal nanoparticles for targeted alpha and hyperthermia therapy. Synthesis, retention studies of r…

Principal investigator: Edyta Cędrowska

Instytut Chemii i Techniki Jądrowej

Call: PRELUDIUM 9, Panel: ST4

27. DNA repair pathways contributing to resistance to photodynamic therapy and as possible theraupeutic targets

Principal investigator: dr hab. Elżbieta Speina

Instytut Biochemii i Biofizyki PAN

Call: OPUS 8, Panel: NZ5

28. Targeting peripheral cannabinoid receptors CB2 as a novel therapy to treat osteoarthritis

Principal investigator: dr hab. Katarzyna Maria Starowicz-Bubak

Instytut Farmakologii PAN

Call: OPUS 7, Panel: NZ7

29. Nanoparticles of gold, gold-gold sulfide and titanium dioxide modified with tellurium as carriers for At-211 for targete…

Principal investigator: prof. Aleksander Józef Bilewicz

Instytut Chemii i Techniki Jądrowej

Call: OPUS 6, Panel: ST4

30. DNA double-stranded break repair proteins as a target for personalized cancer therapy based on synthetic lethality

Principal investigator: dr hab. Tomasz Śliwiński

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: OPUS 4, Panel: NZ7

31. Pathogenesis of ovarian cancer survival in non-adhesion conditions: transcriptomic assessment and studies of molecular t…

Principal investigator: dr Anna Stachurska

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

Call: PRELUDIUM 2, Panel: NZ1

32. Discovery and development of small-molecule inhibitors of USP2 for targeted, non-genotoxic therapy of cancer

Principal investigator: prof. Tadeusz Andrzej Holak

Uniwersytet Jagielloński, Wydział Chemii

Call: OPUS 1, Panel: ST5

33. Janus nanoparticles - research on the effect of the duality of carriers of the activesubstance in targeted therapy of sk…

Principal investigator: dr hab. Bożena Anna Tyliszczak

Politechnika Krakowska im. Tadeusza Kościuszki

Call: OPUS 28, Panel: ST8

34. Human exosomes as natural carriers of protein kinase CK2 inhibitors and degraders in targeted anticancer therapy.

Principal investigator: dr hab. Patrycja Joanna Wińska

Politechnika Warszawska

Call: OPUS 28 (LAP), Panel: NZ5

35. M6A RNA methylation signatures as a targets for HPV-dependent HNSCC therapy

Principal investigator: Kamila Ostrowska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: OPUS 27, Panel: NZ5

36. Radiolabelled up-converting nanoparticles as theranostic agents for multimodal imaging and targeted therapy

Principal investigator: dr Karolina Kinga Zajdel

Narodowe Centrum Badań Jądrowych

Call: SONATINA 8, Panel: ST5

37. Mitochondrial targets of flozins in endothelial cells - a new approach to the prevention, diagnosis and therapy of heart…

Principal investigator: dr hab. Barbara Anna Kutryb-Zając

Gdański Uniwersytet Medyczny, Wydział Lekarski

Call: OPUS 26, Panel: NZ4

38. Bacterial membrane carriers targeting tumor-associated microbes for advanced cancer therapy

Principal investigator: dr Monika Kluzek

Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

Call: OPUS 26, Panel: NZ7

39. Endothelial bioenergetics as a novel target for vascular protection – unveiling the mitochondrial mechanisms of lipid-lo…

Principal investigator: dr Alicja Małgorzata Braczko

Gdański Uniwersytet Medyczny, Wydział Lekarski

Call: PRELUDIUM 22, Panel: NZ5

40. EBI2 receptor as a new myelin repair therapy in multiple sclerosis.

Principal investigator: dr hab. Aleksandra Rutkowska

Gdański Uniwersytet Medyczny, Wydział Lekarski

Call: SONATA 18, Panel: NZ3

41. The role of NPM1 as biomarker of the targeted therapy efficacy in chronic lymphocytic leukemia patients

Principal investigator: prof. Krzysztof Georgios Giannopoulos

Uniwersytet Medyczny w Lublinie, Wydział Lekarski

Call: PRELUDIUM BIS 3, Panel: NZ5

42. Studies on anti-inflammatory properties of GPR18 ligands and their involvement in modulation of microglia phenotypes – a…

Principal investigator: dr hab. Dorota Justyna Łażewska

Uniwersytet Jagielloński, Collegium Medicum

Call: OPUS 22, Panel: NZ7

43. Chronic pain in obesity: from cellular mechanisms to new strategies for targeted therapy.

Principal investigator: dr Anna Piotrowska-Murzyn

Instytut Farmakologii PAN

Call: SONATA 17, Panel: NZ5

44. Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor…

Principal investigator: prof. Barbara Malinowska

Uniwersytet Medyczny w Białymstoku

Call: OPUS 21, Panel: NZ7

45. Mechanisms involved in heme acquisition - potential targets for therapies directed towards reduction of Porphyromonas gi…

Principal investigator: dr Michał Sylwester Śmiga

Uniwersytet Wrocławski, Wydział Biotechnologii

Call: OPUS 21, Panel: NZ6

46. Identification of the interdependence between SWI/SNF-type chromatin remodeling complex, metabolism control and RNA modi…

Principal investigator: prof. Tomasz Jacek Sarnowski

Instytut Biochemii i Biofizyki PAN

Call: OPUS 20, Panel: NZ5

47. Identification of surface proteins as alternate targets for CAR-T therapy against CD19-negative tumors.

Principal investigator: dr hab. Magdalena Hanna Winiarska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: PRELUDIUM BIS 2, Panel: NZ6

48. Drug repurposing to target p53 protein family for improved therapy in the relapsed TP53 and EGFR mutated lung cancer

Principal investigator: dr hab. Alicja Elżbieta Chrzanowska

Warszawski Uniwersytet Medyczny

Call: OPUS 20, Panel: NZ7

49. Targeting deregulated expression of anti-apoptotic proteins belonging to the Bcl-2 family in macrophages as a potential …

Principal investigator: dr Maja Anna Sochalska

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: SONATA 16, Panel: NZ5

50. DNA polymerase θ as a novel therapeutic target in personalized anticancer therapy

Principal investigator: prof. Tomasz Adam Śliwiński

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: OPUS 19, Panel: NZ7

Projects search